Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Bladder Cancer

Free Subscription Articles published in Urol Int Retrieve available abstracts of 32 articles: HTML format

Single Articles

January 2008
1. DEMKOW T , Alter A, Wiechno P
   Intravesical bacillus Calmette-Guerin therapy for T1 superficial bladder cancer.
   Urol Int. 2008;80:74-9.
   PubMed     Related articles    Abstract available
   
   
   
2. HAN KS , Jeong IG, Joung JY, Yang SO, et al
   Clinical value of PTEN in patients with superficial bladder cancer.
   Urol Int. 2008;80:264-9.
   PubMed     Related articles    Abstract available
   
   
   
3. GUNEY S , Guney N, Canogullari Z, Ergenekon E, et al
   Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
   Urol Int. 2008;80:124-8.
   PubMed     Related articles    Abstract available
   
   
   
4. BRIERLY RD , O'Brien TS
   The importance of palliative care in urology.
   Urol Int. 2008;80:13-8.
   PubMed     Related articles    Abstract available
   
   
   
5. BAHK JY , Kim MO, Park MS, Lee HY, et al
   Gonadotropin-releasing hormone (GnRH) and GnRH receptor in bladder cancer epithelia and GnRH effect on bladder cancer cell proliferation.
   Urol Int. 2008;80:431-8.
   PubMed     Related articles    Abstract available
   
   
   
6. SOUKUP V , Babjuk M, Duskova J, Pesl M, et al
   Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
   Urol Int. 2008;80:413-8.
   PubMed     Related articles    Abstract available
   
   
   
7. HUANG SK , Chiu AW, Pu YS, Huang YK, et al
   Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
   Urol Int. 2008;80:405-12.
   PubMed     Related articles    Abstract available
   
   
   
8. CHRISTOPH F , Hinz S, Weikert S, Kempkensteffen C, et al
   Comparative promoter methylation analysis of p53 target genes in urogenital cancers.
   Urol Int. 2008;80:398-404.
   PubMed     Related articles    Abstract available
   
   
   
9. GUICHARD G , Rebibou JM, Ducloux D, Simula-Faivre D, et al
   Lymphocyte subsets in renal transplant recipients with de novo genitourinary malignancies.
   Urol Int. 2008;80:257-63.
   PubMed     Related articles    Abstract available
   
   
   January 2007
10. GIRGIN C , Sezer A, Delibas M, Sahin O, et al
    Impact of the level of muscle invasion in organ-confined bladder cancer.
    Urol Int. 2007;78:145-9.
    PubMed     Related articles    Abstract available
    
    
    
11. RODRIGUEZ FABA O , Fernandez Gomez JM, Palou Redorta J, Escaf Barmadah S, et al
    Significance of collagenase 3 (matrix metalloproteinase 13) in invasive bladder cancer: correlation with pathological parameters.
    Urol Int. 2007;78:140-4.
    PubMed     Related articles    Abstract available
    
    
    
12. SHI B , Zhu Y, Xu Z, Liu Y, et al
    Aggressive fibromatosis in the urological system. Report of two adult patients and review of the literature.
    Urol Int. 2007;78:93-6.
    PubMed     Related articles    Abstract available
    
    
    
13. BUSCARINI M , Quek ML, Gilliam-Hegarich S, Kasahara N, et al
    Adenoviral receptor expression of normal bladder and transitional cell carcinoma of the bladder.
    Urol Int. 2007;78:160-6.
    PubMed     Related articles    Abstract available
    
    
    
14. GONUL II , Poyraz A, Unsal C, Acar C, et al
    Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases.
    Urol Int. 2007;78:338-44.
    PubMed     Related articles    Abstract available
    
    
    
15. POWLES T , Perry J, Shamash J, Liu W, et al
    A Comparison of the Platinum Analogues in Bladder Cancer Cell Lines.
    Urol Int. 2007;79:67-72.
    PubMed     Related articles    Abstract available
    
    
    
16. GAO ZL , Fan J, Zhao JJ, Xia SJ, et al
    Laparoscopic radical cystectomy with extracorporeal ileal conduit urinary diversion for treatment of Chinese bladder cancer patients.
    Urol Int. 2007;79:204-9.
    PubMed     Related articles    Abstract available
    
    
    
17. FERREIRA U , Matheus WE, Nardi Pedro R, Levi D'Ancona CA, et al
    Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate.
    Urol Int. 2007;79:200-3.
    PubMed     Related articles    Abstract available
    
    
    
18. BUSCARINI M , Josephson DY, Stein JP
    Lymphadenectomy in bladder cancer: a review.
    Urol Int. 2007;79:191-9.
    PubMed     Related articles    Abstract available
    
    
    
19. TSAI YS , Tzai TS, Chow NH
    Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?
    Urol Int. 2007;79:210-6.
    PubMed     Related articles    Abstract available
    
    
    
20. SEZHIAN N , Rimal D, Lawrence K, Suresh G, et al
    Squamous cell carcinoma of the bladder following PTFE implantation.
    Urol Int. 2007;79:90-1.
    PubMed     Related articles    Abstract available
    
    
    
21. SALINAS-SANCHEZ AS , Atienzar-Tobarra M, Lorenzo-Romero JG, Sanchez-Sanchez F, et al
    Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.
    Urol Int. 2007;79:321-7.
    PubMed     Related articles    Abstract available
    
    
    January 2006
22. GACCI M , Bartoletti R, Cai T, Nerozzi S, et al
    Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: a pilot study.
    Urol Int. 2006;76:106-11.
    PubMed     Related articles    Abstract available
    
    
    
23. IOACHIM E , Michael M, Salmas M, Michael MM, et al
    Hypoxia-Inducible Factors HIF-1alpha and HIF-2alpha Expression in Bladder Cancer and Their Associations with Other Angiogenesis-Related Proteins.
    Urol Int. 2006;77:255-63.
    PubMed     Related articles    Abstract available
    
    
    
24. RUIFA H , Liwei L, Binxin L, Ximing L, et al
    Additional Gene Therapy with rAAV-wt-p53 Enhanced the Efficacy of Cisplatin in Human Bladder Cancer Cells.
    Urol Int. 2006;77:355-61.
    PubMed     Related articles    Abstract available
    
    
    
25. LIU IJ , Lai YH, Espiritu JI, Segall GM, et al
    Evaluation of fluorodeoxyglucose positron emission tomography imaging in metastatic transitional cell carcinoma with and without prior chemotherapy.
    Urol Int. 2006;77:69-75.
    PubMed     Related articles    Abstract available
    
    
    
26. VARDAR E , Gunlusoy B, Minareci S, Postaci H, et al
    Evaluation of p53 nuclear accumulation in low- and high-grade (WHO/ISUP classification) transitional papillary carcinomas of the bladder for tumor recurrence and progression.
    Urol Int. 2006;77:27-33.
    PubMed     Related articles    Abstract available
    
    
    
27. LEE SE , Byun SS, Hong SK, Chang IH, et al
    Significance of cancer involvement at the ureteral margin detected on routine frozen section analysis during radical cystectomy.
    Urol Int. 2006;77:13-7.
    PubMed     Related articles    Abstract available
    
    
    
28. AGRAWAL S , Khurana N, Mandhani A, Agrawal V, et al
    Primary bladder dermoid: a case report and review of the literature.
    Urol Int. 2006;77:279-80.
    PubMed     Related articles    Abstract available
    
    
    
29. KILCILER M , Bedir S, Erdemir F, Zeybek N, et al
    Comparison of ileal conduit and transureteroureterostomy with ureterocutaneostomy urinary diversion.
    Urol Int. 2006;77:245-50.
    PubMed     Related articles    Abstract available
    
    
    
30. SANLI O , Acar O, Celtik M, Oktar T, et al
    Should Prostate Cancer Status Be Determined in Patients Undergoing Radical Cystoprostatectomy?
    Urol Int. 2006;77:307-310.
    PubMed     Related articles    Abstract available
    
    
    
31. SERRETTA V , Morgia G, Altieri V, Pavone-Macaluso M, et al
    Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder. A study from Gruppo Studi Tumori Urologici Foundation.
    Urol Int. 2006;77:152-8.
    PubMed     Related articles    Abstract available
    
    
    
32. BIRCAN S , Candir O, Kapucuoglu N, Serel TA, et al
    CD10 expression in urothelial bladder carcinomas: a pilot study.
    Urol Int. 2006;77:107-13.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: